You are here

  • Home
  • Archive
  • Volume 6, Issue 1
  • Infliximab associated with faster symptom resolution compared with corticosteroids alone for the management of immune-related enterocolitis

Article info

Article menu

See original article:

Download PDFPDF

Research Article
Infliximab associated with faster symptom resolution compared with corticosteroids alone for the management of immune-related enterocolitis

Authors

  • Daniel H Johnson Section of Rheumatology and Clinical Immunology, Department of General Internal MedicineThe University of Texas MD Anderson Cancer Center Houston TX USA PubMed articlesGoogle scholar articles
  • Chrystia M Zobniw Department of Rheumatology and Rehabilitation, Faculty of MedicineAssiut University Hospitals Assiut Egypt PubMed articlesGoogle scholar articles
  • Van A Trinh Department of Rheumatology and Rehabilitation, Faculty of MedicineAssiut University Hospitals Assiut Egypt PubMed articlesGoogle scholar articles
  • Junsheng Ma Department of BiostatisticsThe University of Texas MD Anderson Cancer Center Houston TX USA PubMed articlesGoogle scholar articles
  • Roland L Bassett Department of BiostatisticsThe University of Texas MD Anderson Cancer Center Houston TX USA PubMed articlesGoogle scholar articles
  • Noha Abdel-Wahab Section of Rheumatology and Clinical Immunology, Department of General Internal MedicineThe University of Texas MD Anderson Cancer Center Houston TX USA Department of Rheumatology and Rehabilitation, Faculty of MedicineAssiut University Hospitals Assiut Egypt PubMed articlesGoogle scholar articles
  • Jaime Anderson Department of Rheumatology and Rehabilitation, Faculty of MedicineAssiut University Hospitals Assiut Egypt PubMed articlesGoogle scholar articles
  • Jennifer E Davis Department of Epidemiology, Division of Cancer Prevention and Population SciencesThe University of Texas MD Anderson Cancer Center Houston TX USA PubMed articlesGoogle scholar articles
  • Jocelyn Joseph Department of Rheumatology and Rehabilitation, Faculty of MedicineAssiut University Hospitals Assiut Egypt PubMed articlesGoogle scholar articles
  • Marc Uemura Section of Rheumatology and Clinical Immunology, Department of General Internal MedicineThe University of Texas MD Anderson Cancer Center Houston TX USA PubMed articlesGoogle scholar articles
  • Ali Noman Department of Gastroenterology, Hepatology, and Nutrition, Division of Internal MedicineThe University of Texas MD Anderson Cancer Center Houston TX USA PubMed articlesGoogle scholar articles
  • Hamzah Abu-Sbeih Department of Gastroenterology, Hepatology, and Nutrition, Division of Internal MedicineThe University of Texas MD Anderson Cancer Center Houston TX USA PubMed articlesGoogle scholar articles
  • Cassian Yee Section of Rheumatology and Clinical Immunology, Department of General Internal MedicineThe University of Texas MD Anderson Cancer Center Houston TX USA PubMed articlesGoogle scholar articles
  • Rodabe Amaria Section of Rheumatology and Clinical Immunology, Department of General Internal MedicineThe University of Texas MD Anderson Cancer Center Houston TX USA PubMed articlesGoogle scholar articles
  • Sapna Patel Section of Rheumatology and Clinical Immunology, Department of General Internal MedicineThe University of Texas MD Anderson Cancer Center Houston TX USA PubMed articlesGoogle scholar articles
  • Hussein Tawbi Section of Rheumatology and Clinical Immunology, Department of General Internal MedicineThe University of Texas MD Anderson Cancer Center Houston TX USA PubMed articlesGoogle scholar articles
  • Isabella C Glitza Section of Rheumatology and Clinical Immunology, Department of General Internal MedicineThe University of Texas MD Anderson Cancer Center Houston TX USA PubMed articlesGoogle scholar articles
  • Michael A Davies Section of Rheumatology and Clinical Immunology, Department of General Internal MedicineThe University of Texas MD Anderson Cancer Center Houston TX USA PubMed articlesGoogle scholar articles
  • Michael K Wong Section of Rheumatology and Clinical Immunology, Department of General Internal MedicineThe University of Texas MD Anderson Cancer Center Houston TX USA PubMed articlesGoogle scholar articles
  • Scott Woodman Section of Rheumatology and Clinical Immunology, Department of General Internal MedicineThe University of Texas MD Anderson Cancer Center Houston TX USA PubMed articlesGoogle scholar articles
  • Wen-Jen Hwu Section of Rheumatology and Clinical Immunology, Department of General Internal MedicineThe University of Texas MD Anderson Cancer Center Houston TX USA PubMed articlesGoogle scholar articles
  • Patrick Hwu Section of Rheumatology and Clinical Immunology, Department of General Internal MedicineThe University of Texas MD Anderson Cancer Center Houston TX USA PubMed articlesGoogle scholar articles
  • Yinghong Wang Department of Gastroenterology, Hepatology, and Nutrition, Division of Internal MedicineThe University of Texas MD Anderson Cancer Center Houston TX USA PubMed articlesGoogle scholar articles
  • Adi Diab Section of Rheumatology and Clinical Immunology, Department of General Internal MedicineThe University of Texas MD Anderson Cancer Center Houston TX USA PubMed articlesGoogle scholar articles
  1. ↵x 713-745-7336 adiab{at}mdanderson.org
View Full Text

Citation

Johnson DH, Zobniw CM, Trinh VA, et al
Infliximab associated with faster symptom resolution compared with corticosteroids alone for the management of immune-related enterocolitis
Journal for ImmunoTherapy of Cancer 2018;6:103. doi: 10.1186/s40425-018-0412-0

Publication history

  • Received July 17, 2018
  • Accepted September 18, 2018
  • First published October 11, 2018.
Online issue publication 
October 11, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.